Items where authors include "Bachelot, T."

Article

Goetz, M.P., Wander, S.A., Bachelot, T. et al. (8 more authors) (2025) ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1-mutated, metastatic breast cancer. Future Oncology, 21 (11). pp. 1317-1324. ISSN 1479-6694

Vendrell, J.A., Robertson, K.E., Ravel, P. et al. (10 more authors) (2008) A candidate molecular signature associated with tamoxifen failure in primary breast cancer. Breast Cancer Research, 10 (5). R88 .

Proceedings Paper

Goetz, M.P., Wander, S.A., Bachelot, T. et al. (17 more authors) (2024) Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating ER+/HER2-, locally advanced or metastatic breast cancer with an ESR1 mutation. In: Journal of Clinical Oncology. 2024 ASCO Annual Meeting, 31 May - 04 Jun 2024, Chicago, USA. American Society of Clinical Oncology .